Skip to main content
CRL logo
CRL
(NYSE)
Charles River Laboratories International, Inc.
$229.29-- (--)
Loading... - Market loading

Charles River Laboratories International (CRL) Stock Price & Financial Analysis

Charles River Laboratories International Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$224.28 - $238.85
52-Week High$238.85
52-Week Low$144.26
Open$234.07
Volume1.07M
Average Volume (3M)862.80K
Market Cap11.22B
Shares Outstanding48.95M
Price to Sales (P/S)2.79
Price to Book (P/B)3.82
EV/EBITDA48.49
Revenue (TTM)4.03B
Net Income (TTM)-184.65M
Free Cash Flow (TTM)391.29M
EPS (TTM)$-3.75
Profit Margin-4.59%
Operating Margin11.77%
Return on Equity (ROE)-6.28%
Debt to Equity1.04
50-Day MA$195.53
200-Day MA$185.39
52-Week Change36.52%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Charles River Laboratories International

What is the current stock price for CRL?

As of the latest trading session, CRL stock trades at $229.29. The 52-week range is $144.26–$238.85, with a day range of $224.28–$238.85.

What is the P/E ratio for CRL?

The P/E ratio (Price-to-Earnings) for CRL is shown in the Key Statistics section. This valuation metric helps compare Charles River Laboratories International, Inc. to industry peers.

Does CRL pay dividends?

Charles River Laboratories International does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CRL?

Based on 13 analysts, the consensus for CRL is Buy.

What is the market cap of CRL?

Charles River Laboratories International's market capitalization is $11.22B, classifying it as a large-cap company. Charles River Laboratories International operates in the Healthcare sector within the Diagnostics & Research industry.